Zelegent Acquires MISH Technology Platform, Extending Product Pipeline into Obstructive Sleep Apnea Therapeutics
15. September 2019 06:36 ET
|
Zelegent, Inc.
While Elevoplasty® Grows in Recognition and Popularity with Physicians, MISH Platform Allows for Development of 2nd Product with Same Sales Call Point LA JOLLA, CA, Sept. 15, 2019 (GLOBE...
Cook Medical and Zelegent, Inc. begin sales and marketing agreement
08. Januar 2019 14:03 ET
|
Zelegent, Inc.
Bloomington, Ind. and La Jolla, Calif, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Today, Cook Medical and Zelegent, Inc. announce an agreement to enhance treatment options for patients suffering from...
Zelegent, Inc. Elevoplasty™ Procedure Receives U.S. Patent
21. Juni 2018 14:33 ET
|
Zelegent, Inc.
First issued patent of a portfolio of applications covering the new minimally-invasive procedure to treat snoring IRVINE, CA, June 21, 2018 (GLOBE NEWSWIRE) -- Zelegent, Inc., a medical...
Zelegent, Inc. Launches Multi-Center Snoring Reduction Trial
13. März 2017 10:15 ET
|
Zelegent, Inc.
IRVINE, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- Zelegent, Inc., a clinical-stage medical technology company developing innovative tools for otolaryngologist sleep specialists, today announced the...